Pensionfund Sabic grew its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 90.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,500 shares of the medical research company's stock after acquiring an additional 5,000 shares during the period. Pensionfund Sabic's holdings in Agilent Technologies were worth $1,411,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $28,000. Ashton Thomas Securities LLC acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $31,000. Fortitude Family Office LLC grew its stake in Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock worth $35,000 after acquiring an additional 95 shares during the period. RPg Family Wealth Advisory LLC purchased a new stake in Agilent Technologies in the 3rd quarter worth approximately $38,000. Finally, Ashton Thomas Private Wealth LLC purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $39,000. 87.42% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A has been the subject of several recent analyst reports. StockNews.com raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Evercore ISI lifted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 1st. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research note on Monday, December 9th. Citigroup boosted their price objective on shares of Agilent Technologies to $165.00 and gave the company a "buy" rating in a research note on Thursday, December 19th. Finally, Barclays lowered their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set an "underweight" rating for the company in a research note on Wednesday, November 27th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $143.62.
Check Out Our Latest Stock Report on Agilent Technologies
Agilent Technologies Stock Up 0.7 %
A stock traded up $1.01 during trading on Tuesday, reaching $137.44. The stock had a trading volume of 1,056,693 shares, compared to its average volume of 1,076,023. Agilent Technologies, Inc. has a 1-year low of $124.16 and a 1-year high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $39.25 billion, a P/E ratio of 31.10, a PEG ratio of 4.48 and a beta of 1.06. The firm has a fifty day moving average price of $135.59 and a 200 day moving average price of $136.69.
Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the business posted $1.38 EPS. The firm's revenue was up .8% compared to the same quarter last year. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.
Agilent Technologies Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.24. Agilent Technologies's dividend payout ratio is 22.40%.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
See Also
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.